Journal of Trauma and Injury

The Korean Society of Traumatology (대한외상학회)
권호 표지
DOI QR코드

DOI QR Code

Usefulness of presepsin as a prognostic indicator for patients with trauma in the emergency department in Korea: a retrospective study

  • Si Woo Kim (Department of Emergency Medicine, Korea University Guro Hospital, Korea University College of Medicine) ;
  • Jung-Youn Kim (Department of Emergency Medicine, Korea University Guro Hospital, Korea University College of Medicine) ;
  • Young-Hoon Yoon (Department of Emergency Medicine, Korea University Guro Hospital, Korea University College of Medicine) ;
  • Sung Joon Park (Department of Emergency Medicine, Korea University Guro Hospital, Korea University College of Medicine) ;
  • Bo Sun Shim (Department of Emergency Medicine, Korea University Guro Hospital, Korea University College of Medicine)
  • Received : 2023.09.07
  • Accepted : 2023.10.31
  • Published : 2024.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Trauma is an important public health concern, and it is important to increase the survival rate of patients with trauma and enable them to return to society in a better condition. Initial treatment in the emergency department (ED) is closely associated with the prognosis of patients with trauma. However, studies regarding laboratory biomarker tests that can help predict the prognosis of trauma patients are limited. Presepsin is a novel biomarker of inflammation that can predict a poor prognosis in patients with sepsis. This study aimed to determine whether presepsin could be used as a prognostic indicator in patients with polytrauma. Methods: The study included patients with trauma who had visited a single regional ED from November 2021 to January 2023. Patients who had laboratory tests in the ED were included and analyzed retrospectively through chart review. Age, sex, injury mechanism, vital signs, surgery, the outcome of ED treatment (admission, discharge, transfer, or death), and trauma scores were analyzed. Results: Overall, 550 trauma patients were enrolled; 59.1% were men, and the median age was 64 years (interquartile range, 48.8-79.0 years). Patients in a hypotensive state (systolic blood pressure, <90 mmHg; n=39) had higher presepsin levels (1,061.5±2,522.7 pg/mL) than those in a nonhypotensive state (n=511, 545.7±688.4 pg/mL, P<0.001). Patients hospitalized after ED treatment had the highest presepsin levels (660.9 pg/mL), followed by those who died (652.0 pg/ mL), were transferred to other hospitals (514.9 pg/mL), and returned home (448.0 pg/mL, P=0.041). Conclusions: Serum presepsin levels were significantly higher in trauma patients in a hypotensive state than in those in a nonhypotensive state. Additionally, serum presepsin levels were the highest in hospitalized patients with trauma, followed by those who died, were transferred to other hospitals, and returned home.

Keywords

References

  1. Prin M, Li G. Complications and in-hospital mortality in trauma patients treated in intensive care units in the United States, 2013. Inj Epidemiol 2016;3:18.
  2. Tintinalli JE, Ma O, Yealy DM, et al. Tintinalli's emergency medicine: a comprehensive study guide. 2nd ed. McGraw Hill; 2020.
  3. Hokkam E, Gonna A, Zakaria O, El-Shemally A. Trauma patterns in patients attending the Emergency Department of Jazan General Hospital, Saudi Arabia. World J Emerg Med 2015;6:48-53. https://doi.org/10.5847/wjem.j.1920-8642.2015.01.009
  4. Kang J, Gong P, Zhang XD, Wang WJ, Li CS. Early differential value of plasma presepsin on infection of trauma patients. Shock 2019;52:362-9. https://doi.org/10.1097/SHK.0000000000001269
  5. Demetriades D, Kimbrell B, Salim A, et al. Trauma deaths in a mature urban trauma system: is "trimodal" distribution a valid concept. J Am Coll Surg 2005;201:343-8. https://doi.org/10.1016/j.jamcollsurg.2005.05.003
  6. Marshall JC, Reinhart K; International Sepsis Forum. Biomarkers of sepsis. Crit Care Med 2009;37:2290-8. https://doi.org/10.1097/CCM.0b013e3181a02afc
  7. Chaudhry H, Zhou J, Zhong Y, et al. Role of cytokines as a double-edged sword in sepsis. In Vivo 2013;27:669-84.
  8. Zanoni I, Granucci F. Role of CD14 in host protection against infections and in metabolism regulation. Front Cell Infect Microbiol 2013;3:32.
  9. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-3. https://doi.org/10.1126/science.1698311
  10. Schumann RR. Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review. Res Immunol 1992;143:11-5. https://doi.org/10.1016/0923-2494(92)80074-U
  11. Zou Q, Wen W, Zhang XC. Presepsin as a novel sepsis biomarker. World J Emerg Med 2014;5:16-9. https://doi.org/10.5847/wjem.j.issn.1920-8642.2014.01.002
  12. Meuleman P, Steyaert S, Libbrecht L, et al. Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection. Clin Chim Acta 2006;366:156-62. https://doi.org/10.1016/j.cca.2005.09.022
  13. Su GL, Dorko K, Strom SC, Nussler AK, Wang SC. CD14 expression and production by human hepatocytes. J Hepatol 1999;31:435-42. https://doi.org/10.1016/S0168-8278(99)80034-8
  14. Mussap M, Noto A, Fravega M, Fanos V. Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers. J Matern Fetal Neonatal Med 2011;24 Suppl 2:12-4.
  15. Yaegashi Y, Shirakawa K, Sato N, et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother 2005;11:234-8. https://doi.org/10.1007/s10156-005-0400-4
  16. Zhang J, Hu ZD, Song J, Shao J. Diagnostic value of presepsin for sepsis: a systematic review and meta-analysis. Medicine (Baltimore) 2015;94:e2158.
  17. Chenevier-Gobeaux C, Borderie D, Weiss N, Mallet-Coste T, Claessens YE. Presepsin (sCD14-ST), an innate immune response marker in sepsis. Clin Chim Acta 2015;450:97-103. https://doi.org/10.1016/j.cca.2015.06.026
  18. Ackland GL, Prowle JR. Presepsin: solving a soluble (CD14) problem in sepsis? Intensive Care Med 2015;41:351-3. https://doi.org/10.1007/s00134-014-3642-8
  19. Jersmann HP. Time to abandon dogma: CD14 is expressed by non-myeloid lineage cells. Immunol Cell Biol 2005;83:462-7. https://doi.org/10.1111/j.1440-1711.2005.01370.x
  20. Endo S, Suzuki Y, Takahashi G, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother 2012;18:891-7. https://doi.org/10.1007/s10156-012-0435-2
  21. Carpio R, Zapata J, Spanuth E, Hess G. Utility of presepsin (sCD14-ST) as a diagnostic and prognostic marker of sepsis in the emergency department. Clin Chim Acta 2015;450: 169-75. https://doi.org/10.1016/j.cca.2015.08.013
  22. Ulla M, Pizzolato E, Lucchiari M, et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care 2013;17:R168.
  23. Liu B, Chen YX, Yin Q, Zhao YZ, Li CS. Diagnostic value and prognostic evaluation of presepsin for sepsis in an emergency department. Crit Care 2013;17:R244.
  24. Romualdo LG, Torrella PE, Gonzalez MV, et al. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department. Clin Biochem 2014;47:505-8. https://doi.org/10.1016/j.clinbiochem.2014.02.011
  25. Desborough JP. The stress response to trauma and surgery. Br J Anaesth 2000;85:109-17. https://doi.org/10.1093/bja/85.1.109
  26. Arai Y, Mizugishi K, Nonomura K, Naitoh K, Takaori-Kondo A, Yamashita K. Phagocytosis by human monocytes is required for the secretion of presepsin. J Infect Chemother 2015;21:564-9. https://doi.org/10.1016/j.jiac.2015.04.011
  27. Egger G, Aigner R, Glasner A, Hofer HP, Mitterhammer H, Zelzer S. Blood polymorphonuclear leukocyte migration as a predictive marker for infections in severe trauma: comparison with various inflammation parameters. Intensive Care Med 2004;30:331-4. https://doi.org/10.1007/s00134-003-2111-6
  28. Salluh JIF, Souza-Dantas VC, Povoa P. The current status of biomarkers for the diagnosis of nosocomial pneumonias. Curr Opin Crit Care 2017;23:391-7. https://doi.org/10.1097/MCC.0000000000000442
  29. Matwiyoff GN, Prahl JD, Miller RJ, et al. Immune regulation of procalcitonin: a biomarker and mediator of infection. Inflamm Res 2012;61:401-9. https://doi.org/10.1007/s00011-012-0439-5